Pathstone Holdings
AMED

Pathstone Holdings’s Amedisys AMED Stock Holding History

Pathstone Holdings’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,996
Closed -$272K – 2246
2024
Q4 		$272K Sell
2,996
-1,098
-27% -$101K ﹤0.01% 2008
2024
Q3 		$395K Sell
4,094
-118
-3% -$11.5K ﹤0.01% 1850
2024
Q2 		$387K Sell
4,212
-339
-7% -$31.5K ﹤0.01% 1823
2024
Q1 		$419K Buy
4,551
+1,910
+72% +$179K ﹤0.01% 1761
2023
Q4 		$251K Buy
+2,641
New +$247K ﹤0.01% 1939

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Pathstone Holdings's AMED Position: Q1 2025 in Review

Pathstone Holdings sold out of Amedisys (AMED) in Q1 2025, closing a stake of 2,996 shares — an estimated $272K sold.

Pathstone Holdings first reported a position in AMED in Q4 2023 and held it in 5 quarters. The position peaked at $419K in Q1 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Pathstone Holdings reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 2,996 Amedisys shares in Q1 2025, an estimated $272K.
  • Pathstone Holdings first reported a position in Amedisys in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's Amedisys position peaked at $419K in Q1 2024.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.